Jagsonpal Pharmaceuticals Ltd.
| BSE: 507789 | Sector: Health care |
| NSE: JAGSNPHARM | ISIN Code: INE048B01027 |
| BSE 00:00 | 24 Sep | 152.05 |
-2.05 (-1.33%) |
OPEN
153.90 |
HIGH
155.95 |
LOW
150.65 |
| NSE 00:00 | 24 Sep | 151.45 |
-2.55 (-1.66%) |
OPEN
155.95 |
HIGH
155.95 |
LOW
150.00 |
| OPEN | 153.90 |
| PREVIOUS CLOSE | 154.10 |
| VOLUME | 9229 |
| 52-Week high | 203.25 |
| 52-Week low | 35.45 |
| P/E | 18.63 |
| Mkt Cap.(Rs cr) | 398 |
| Buy Price | 0.00 |
| Buy Qty | 0.00 |
| Sell Price | 0.00 |
| Sell Qty | 0.00 |
Jagsonpal Pharmaceuticals Ltd. (JAGSNPHARM) - Latest News & Headlines
-
Jagsonpal Pharmaceuticals Ltd Announcement under Regulation 30 (LODR)-Newspaper Publication
09/09/2021 | bse |
Downlaod PDF -
Jagsonpal Pharmaceuticals Ltd Record Date For Dividend And Annual General Meeting
07/09/2021 | bse |
Downlaod PDF -
Jagsonpal Pharmaceuticals Ltd Book Closure For 42Nd Annual General Meeting.
07/09/2021 | bse |
Downlaod PDF -
Jagsonpal Pharmaceuticals Ltd Annual General Meeting On 30 September 2021 At 1100 Hours.
07/09/2021 | bse |
Downlaod PDF -
Jagsonpal Pharmaceuticals Ltd Reg. 34 (1) Annual Report
07/09/2021 | bse |
Downlaod PDF
-
Birlas fail to nominate directors on the board of MP Birla group companies
9.39 pm | 24 Sep 2021 | Business Standard
The AGM of MP Birla group's flagship, Birla Corporation will be held on September 29
-
JBF Ind hits 5% upper circuit for 2nd straight day on RIL takeover buzz
2.38 pm | 23 Sep 2021 | Business Standard
RIL, meanwhile, said that there are no negotiations which are taking place for Reliance to takeover JBF Industries or its assets
-
Stocks to watch: Wipro, Zomato, Welspun India, Lupin, Rail Vikas Nigam
8.53 am | 20 Sep 2021 | Business Standard
MAS Financial Services has raised Rs 100 crore through private placement of market-linked non-convertible debentures
-
Vaishali Parekh of Prabhudas Lilladher recommends buying M&M, Himadri
7.58 am | 20 Sep 2021 | Business Standard
Mahindra & Mahindra has made a triple bottom formation on the daily chart, can target Rs 850 on the upside, says the technical analyst
-
Here's why Osho Krishan expects HDFC to reclaim lifetime high soon
8.35 am | 17 Sep 2021 | Business Standard
The technical analyst from Anand Rathi is also bullish on SBI Cards and Jubilant Ingrevia
Quick Links for Jagsonpal Pharmaceuticals:
-
News
Announcements Brokerage Reports Business Earnings Sector -
Corporate Action
AGM Board Meetings Bonus Dividends EGM Rights Split -
INFORMATION
Bulk Deals Company History MF Holding Listing Info Locations Shareholding -
Financials
Financial Overview Balance Sheet Profit & Loss Cash Flow Ratios Quarterly Results Half Yearly Results Nine Monthly Results Yearly Results -
Annual Report
Auditors Report Chairman's Speech Company Management Directors' Report Finished Goods Raw Materials -
Peer Comparison
Competition Market Cap Price Price Performance Net Sales Net Profit Total Assets Historical Prices
